fda bpc 157 statement The Precision Peptide Company Applauds Advisory Committee Vote on Expanded Pathway for BPC-157 and KPV An FDA advisory committee voted

An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with fda statement bpc 157 The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety The FDA just dropped a 68 page PDF on if BPC 157 should be legal or not to compound. Their initial recommendation: DO NOT add BPC 157 to the 503A Bulks List. They're meeting this FDA panel backs easier access to peptides KNKX Public Radio

SKU: 50923002329 · From iglepidom.org